Virtual care and digital therapeutics platform
| Date | Round | Amount |
|---|---|---|
| May 2022 | Series D Plus Biofourmis, a Boston-based virtual care and digital medicine company, raised a $300M Series D led by General Atlantic at a unicorn valuation, with CVS Health and SoftBank Vision Fund 2 participating. | $300M |